Drugs in R&D publishes original research and reviews from all phases of drug development and on clinical use of drugs following approval.

The journal was re-launched in 2010 as the first Open Access journal from Adis, making all content from 2010 onwards freely available online. Pre-2010 content is not available as Open Access.

Drugs in R&D offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Manuscripts submitted to the journal for publication will be subject to an article processing charge (APC) upon acceptance. Please click on the ‘Fees and funding’ link for details of the current APC and open access funding and support services. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.

Journal information

Editor
  • Anton van Rensburg
Publishing model
Open Access. Learn about publishing OA with us

Journal metrics

2.594 (2020)
Impact factor
3.435 (2020)
Five year impact factor
55 days
Submission to first decision
166,168 (2020)
Downloads

Latest articles

Journal updates

  • Digital Features

    Drugs in R&D is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

About this journal

Electronic ISSN
1179-6901
Print ISSN
1174-5886
Abstracted and indexed in
  1. CLOCKSS
  2. CNKI
  3. CNPIEC
  4. Chemical Abstracts Service (CAS)
  5. DOAJ
  6. Dimensions
  7. EBSCO Academic Search
  8. EBSCO Advanced Placement Source
  9. EBSCO Biomedical Reference Collection
  10. EBSCO Discovery Service
  11. EBSCO STM Source
  12. EMBASE
  13. Gale
  14. Google Scholar
  15. Medline
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. Portico
  19. ProQuest-ExLibris Primo
  20. ProQuest-ExLibris Summon
  21. PubMedCentral
  22. Reaxys
  23. SCImago
  24. SCOPUS
  25. Science Citation Index Expanded (SciSearch)
  26. Semantic Scholar
  27. TD Net Discovery Service
  28. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG